Showing results (51-60 of 174) with videos related to
Sort By:
Pageof 18
Cancers|August 19, 2020
Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell TransplantationChristina Rautenberg, Anika Bergmann, Ulrich Germing, et al.Experimental Hematology|November 3, 2007
Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosisNicolaus Kröger, Jürgen Thiele, Axel Zander, et al.Cancers|December 23, 2022
Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic ComponentVictoria Platte, Anika Bergmann, Barbara Hildebrandt, et al.Cancers|November 14, 2023
Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation-Results from the LenaMain Trial (NCT00891384)Amelie Boquoi, Aristoteles Giagounidis, Hartmut Goldschmidt, et al.Blood Cancer Journal|November 13, 2019
EASIX for prediction of survival in lower-risk myelodysplastic syndromesAlmuth Merz, Ulrich Germing, Guido Kobbe, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantationCharalampia Kyriakou, Carmen Canals, Jürgen Finke, et al.British Journal of Haematology|August 23, 2012
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allograftingEvgeny Klyuchnikov, Ernst Holler, Martin Bornhäuser, et al.British Journal of Haematology|April 14, 2006
Delayed diagnosis and complications of Fanconi anaemia at advanced age--a paradigmKirsten Huck, Helmut Hanenberg, Sonja Gudowius, et al.Transplantation|November 20, 2002
Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantationGuido Kobbe, Ulrich Germing, Manuel Aivado, et al.European Journal of Haematology|October 30, 2013
Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasmsYuewen Fu, Thomas Schroeder, Tatjana Zabelina, et al.Pageof 18